Mr. Conrad Pinette

Mr. Conrad Pinette
Team: 
Board of Directors
Positions: 

Chairman of the Board

Conrad Pinette was born in Manitoba, relocated to British Columbia in 1950 and educated at Private Schools in British Columbia and a program at UBC. He completed four years of a five Program in Forestry and Business Administration at UBC before returning to Williams Lake, BC to manage Family Businesses. Mr. Pinette sold the Family Forest Products business to British Columbia Forest Products Limited in 1982 and continued in Senior Executive positions with BCFP and Fletcher Challenge Canada Limited until 1990. 

Mr. Pinette joined Lignum Limited, a private forest products company, in 1990 as President and Chief Operating Officer. When it was sold to Riverside Forest Products Limited in December 2004, he continueed as Executive Vice President of Riverside until it was acquired by Tolko Industries Ltd in October 2005. He assisted Tolko in the integration of Riverside and Tolko from October 2005 to December 2006. 

A professional Director for a number of Forest Industry Public Companies and Mining Industry Companies from 1985 through 2011, Mr. Pinette was also Chairman of Finning Inernational Inc. from 2005 to 2011.

He is currently a Director of Canfor Corporation, Canfor Pulp Inc., Cariboo Foundation and the VGH and UBC Prostate Advisory Board.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Movember Foundation 2018

Movember 2018

The Movember Foundation's fundraiser runs from November 1 to 30.  Click here to donate to The Vancouver Prostate Centre team as we join teams across Canada to raise funds for men's health research in the areas of prostate cancer, testicular cancer, mental health and suicide prevention.

Employment

Work at the Vancouver Prostate Centre

Tuesday, November 27, 2018

An innovative new study advances personalized medicine for prostate cancer patients

Drs Chi and Wyatt
Tuesday, October 23, 2018

Three researchers receive Prostate Cancer Canada & Movember Foundation grants for biomarker development